Effect of iodine concentration of contrast media on contrast enhancement in multislice CT of the pancreas

British Journal of Radiology

Volumn 77, Issue 922, 2004, Pages 821-830

  Fenchel, Sabine ^a,b   Fleiter, T R ^a,b   Aschoff, A J ^a   van Gessel, R ^c   Brambs, H J ^a   Merkle, E M ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALTANA Pharma   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; IOMEPROL; NONIONIC CONTRAST MEDIUM; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; IOPAMIDOL; RADIOACTIVE IODINE;

ADULT; AGE; AGED; AORTA; ARTERY; ARTERY DIAMETER; ARTICLE; BODY HEIGHT; BODY WEIGHT; CANCER INFILTRATION; CELIAC ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION RESPONSE; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; INTESTINE WALL; KIDNEY; MALE; MEASUREMENT; PANCREAS; PANCREAS CARCINOMA; PANCREAS TUMOR; PANCREATOGRAPHY; PORTAL VEIN; QUALITATIVE ANALYSIS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SMALL INTESTINE; SPLEEN; STATISTICAL SIGNIFICANCE; SUPERIOR MESENTERIC ARTERY; CHEMISTRY; COHORT ANALYSIS; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY;

ADULT; AGED; COHORT STUDIES; CONTRAST MEDIA; FEMALE; HUMANS; IODINE; IODINE RADIOISOTOPES; IOPAMIDOL; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 7744240438     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/19527646     Document Type: Article

References (27)

1. Baum U, Lell M, Nomayr A, Wolf H, Brunner T, Greess H, et al. [Multiplanar spiral CT in the diagnosis of pancreatic tumors]. Radiologe 1996;39:958-64.
2. Boland GW, O'Malley ME, Saez M, Fernandez-del-Castillo C, Warshaw AL, Mueller PR. Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma. AJR Am J Roentgenol 1999;172:605-8.
3. Choi BI, Chung MJ, Han JK, Han MC, Yoon YB. Detection of pancreatic adenocarcinoma: relative value of arterial and late phases of spiral CT. Abdom Imaging 1997;22:199-203.
4. Engeroff B, Kopka L, Harz C, Grabbe E. [Impact of different iodine concentrations on abdominal enhancement in biphasic multislice helical CT (MS-CT)]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2001;173:938-41.
5. Graf O, Boland GW, Warshaw AL, Fernandez-del-Castillo C, Hahn PF, Mueller PR. Arterial versus portal venous helical CT for revealing pancreatic adenocarcinoma: conspicuity of tumor and critical vascular anatomy. AJR Am J Roentgenol 1997;169:119-23.
6. Keogan MT, McDermott VG, Paulson EK, Sheafor DH, Frederick MG, de Long DM, et al. Pancreatic malignancy: effect of dual-phase helical CT in tumor detection and vascular opacification. Radiology 1997;205:513-8.
7. Kim T, Murakami T, Takahashi S, Okada A, Hori M, Narumi Y, et al. Pancreatic CT imaging: effects of different injection rates and doses of contrast material. Radiology 1999;212:219-25.
8. Kopka L, Rogalla P, Hamm B. [Multislice CT of the abdomen - current indications and future trends]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002; 174:273-82.
9. Lu DS, Vedantham S, Krasny RM, Kadell B, Berger WL, Reber HA. Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures. Radiology 1996;199: 697-701.
10. Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol 1997;168:1439-43.
11. McNulty NJ, Francis IR, Platt JF, Cohan RH, Korobkin M, Gebremariam A. Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 2001;220:97-102.
12. Raptopoulos V, Steer ML, Sheiman RG, Vrachliotis TG, Gougoutas CA, Movson JS. The use of helical CT and CT angiography to predict vascular involvement from pancreatic cancer: correlation with findings at surgery. AJR Am J Roentgenol 1997;168:971-7.
13. Tabuchi T, Itoh K, Ohshio G, Kojima N, Maetani Y, Shibata T, et al. Tumor staging of pancreatic adenocarcinoma using early- and late-phase helical CT. AJR Am J Roentgenol 1999;173:375-80.
14. Johnson CD. Pancreatic carcinoma: developing a protocol for multi-detector row CT. Radiology 2001;220:3-4.
15. Tublin ME, Tessler FN, Cheng SL, Peters TL, McGovern PC. Effect of injection rate of contrast medium on pancreatic and hepatic helical CT. Radiology 1999;210:97-101.
16. Valls C, Andia E, Sanchez A, Fabregat J, Pozuelo O, Quintero JC, et al. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR Am J Roentgenol 2002;178:821-6.
17. Kopka L, Funke M, Fischer U, Vosshenrich R, Oestmann JW, Grabbe E. Parenchymal liver enhancement with bolus-triggered helical CT: preliminary clinical results. Radiology 1995;195:282-4.
18. Silverman PM, Brown B, Wray H, Fox SH, Cooper C, Roberts S, et al. Optimal contrast enhancement of the liver using helical (spiral) CT: value of SmartPrep. AJR Am J Roentgenol 1995;164:1169-71.
19. Kim T, Murakami T, Takahashi S, Tsuda K, Tomoda K, Narumi Y, et al. Effects of injection rates of contrast material on arterial phase hepatic CT. AJR Am J Roentgenol 1998;171:429-32.
20. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. Part I. Prediction with a computer model. Radiology 1998;207:647-55.
21. Freeny PC, Gardner JC, vonIngersleben G, Heyano S, Nghiem HV, Winter TC. Hepatic helical CT: effect of reduction of iodine dose of intravenous contrast material on hepatic contrast enhancement. Radiology 1995;197:89-93.
22. Herts BR, Paushter DM, Einstein DM, Zepp R, Friedman RA, Obuchowski N. Use of contrast material for spiral CT of the abdomen: comparison of hepatic enhancement and vascular attenuation for three different contrast media at two different delay times. AJR Am J Roentgenol 1995;164:327-31.
23. Yamashita Y, Komohara Y, Takahashi M, Uchida M, Hayabuchi N, Shimizu T, et al. Abdominal helical CT: evaluation of optimal doses of intravenous contrast material - a prospective randomized study. Radiology 2000; 216:718-23.
24. Gerlowski LE, Jain RK. Physiologically based pharmacokinetic modeling: principles and applications. J Pharm Sci 1983;72:1103-27.
25. Kopka L, Rodenwaldt J, Fischer U, Mueller DW, Oestmann JW, Grabbe E. Dual-phase helical CT of the liver: effects of bolus tracking and different volumes of contrast material. Radiology 1996;201:321-6.
26. Silverman PM, Roberts S, Tefft MC, Brown B, Fox SH, Cooper C, et al. Helical CT of the liver: clinical application of an automated computer technique, SmartPrep, for obtaining images with optimal contrast enhancement. AJR Am J Roentgenol 1995;165:73-8.
27. Dooley M, Jarvis B. Iomeprol, a review of its use as a contrast medium. Drugs 2000;5:1169-86.